IS5840A - Setnar oxazól og þíazól afleiður sem hPPAR gamma og hPPAR alfa hvatar - Google Patents

Setnar oxazól og þíazól afleiður sem hPPAR gamma og hPPAR alfa hvatar

Info

Publication number: IS5840A
Authority: IS; Iceland
Prior art keywords: hppar; oxazole; substitutes; gamma; thiazole derivatives
Prior art date: 1998-08-07

Application number

IS5840A

Other languages

English (en)

Inventor

Loren Collins Jon

Mark Willson Timothy

Alan Oplinger Jeffrey

Duzube Milana

Original Assignee

Glaxo Group Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-07

Filing date

2001-02-05

Publication date

2001-02-05

2001-02-05 Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited

2001-02-05 Publication of IS5840A publication Critical patent/IS5840A/is

Links

101000741788 Homo sapiens Peroxisome proliferator-activated receptor alpha Proteins 0.000 title 2
102100038831 Peroxisome proliferator-activated receptor alpha Human genes 0.000 title 2
ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 title 1
239000003054 catalyst Substances 0.000 title 1
150000007979 thiazole derivatives Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Hematology (AREA)
Obesity (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Thiazole And Isothizaole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IS5840A 1998-08-07 2001-02-05 Setnar oxazól og þíazól afleiður sem hPPAR gamma og hPPAR alfa hvatar IS5840A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9817118.4A GB9817118D0 (en)	1998-08-07	1998-08-07	Pharmaceutical compounds
PCT/EP1999/005666 WO2000008002A1 (en)	1998-08-07	1999-08-05	SUBSTITUTED OXAZOLES AND THIAZOLES DERIVATIVES AS hPPAR GAMMA AND hPPAR ALPHA ACTIVATORS

Publications (1)

Publication Number	Publication Date
IS5840A true IS5840A (is)	2001-02-05

Family

ID=10836805

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5840A IS5840A (is)	1998-08-07	2001-02-05	Setnar oxazól og þíazól afleiður sem hPPAR gamma og hPPAR alfa hvatar

Country Status (31)

Country	Link
US (1)	US6498174B1 (is)
EP (1)	EP1102757B1 (is)
JP (1)	JP2002522426A (is)
KR (1)	KR20010085340A (is)
CN (1)	CN1321152A (is)
AP (1)	AP2001002066A0 (is)
AR (1)	AR020001A1 (is)
AT (1)	ATE264313T1 (is)
AU (1)	AU5731099A (is)
BR (1)	BR9912866A (is)
CA (1)	CA2339773A1 (is)
CO (1)	CO5070570A1 (is)
CZ (1)	CZ2001490A3 (is)
DE (1)	DE69916457T2 (is)
EA (1)	EA200100105A1 (is)
EE (1)	EE200100074A (is)
ES (1)	ES2220110T3 (is)
GB (1)	GB9817118D0 (is)
HR (1)	HRP20010095A2 (is)
HU (1)	HUP0103469A3 (is)
ID (1)	ID29543A (is)
IL (1)	IL141248A0 (is)
IS (1)	IS5840A (is)
MA (1)	MA26668A1 (is)
NO (1)	NO20010628L (is)
PE (1)	PE20000947A1 (is)
PL (1)	PL345882A1 (is)
SK (1)	SK1962001A3 (is)
TR (1)	TR200100372T2 (is)
WO (1)	WO2000008002A1 (is)
ZA (1)	ZA200100983B (is)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU7073400A (en)	1999-08-27	2001-03-26	Eli Lilly And Company	Biaryl-oxa(thia)zole derivatives and their use as ppars modulators
EP1939188A1 (en) *	1999-09-22	2008-07-02	Bristol-Myers Squibb Company	Oxa-and thiazole derivatives useful as antidiabetic and antiobesity agents
TWI260321B (en)	1999-09-22	2006-08-21	Bristol Myers Squibb Co	Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
US6414002B1 (en)	1999-09-22	2002-07-02	Bristol-Myers Squibb Company	Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
GB0002667D0 (en) *	2000-02-04	2000-03-29	Glaxo Group Ltd	medicamesnts
GB0031103D0 (en) *	2000-12-20	2001-01-31	Glaxo Group Ltd	Chemical compounds
US20040072838A1 (en)	2000-12-20	2004-04-15	Pierette Banker	Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
WO2002076959A1 (en) *	2001-03-23	2002-10-03	Takeda Chemical Industries, Ltd.	Five-membered heterocyclic alkanoic acid derivative
GB0111523D0 (en) *	2001-05-11	2001-07-04	Glaxo Group Ltd	Chemical compounds
DE60211891T2 (de) *	2001-05-15	2007-05-24	F. Hoffmann-La Roche Ag	Carbonsäure-substituierte oxazol-derivate zur verwendung als ppar-alpha und -gamma aktivatoren zur behandlung von diabetes
BR0209711A (pt)	2001-05-29	2004-11-03	Kyoto Pharma Ind	Composto heterocìclico e seu uso medicinal
HUP0400023A2 (hu)	2001-05-29	2004-04-28	Kyoto Pharmaceutical Industries, Ltd.	Új heterociklusos származékok és gyógyászati alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
US6861440B2 (en)	2001-10-26	2005-03-01	Hoffmann-La Roche Inc.	DPP IV inhibitors
TW200300681A (en)	2001-11-12	2003-06-16	Ono Pharmaceutical Co	Carboxylic acid derivative compound and medicament containing same as active ingredient
JP3884736B2 (ja)	2002-01-17	2007-02-21	トーアエイヨー株式会社	ハロゲノベンジルアミノプロピオン酸誘導体
US6716842B2 (en)	2002-04-05	2004-04-06	Warner-Lambert Company, Llc	Antidiabetic agents
US20050119314A1 (en) *	2002-04-05	2005-06-02	Sankyo Company, Limited	Pharmaceutical composition comprising an ACAT inhibitor and an insulin resistance reducing agent
KR100474202B1 (ko) *	2002-05-04	2005-03-08	강헌중	티아졸 유도체의 제조방법 및 이를 제조하기 위한 중간체
JP4290648B2 (ja)	2002-07-03	2009-07-08	エフ．ホフマン−ラロシュアーゲー	オキサゾール誘導体及びインスリン感作物質としてのそれらの使用
WO2004004665A2 (en)	2002-07-09	2004-01-15	Bristol-Myers Squibb Company	Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
PL375779A1 (en) *	2002-08-30	2005-12-12	F.Hoffmann-La Roche Ag	Novel 2-arylthiazole compounds as pparalpha and ppargamma agonists
EP1539746B1 (en)	2002-09-12	2006-11-15	F. Hoffmann-La Roche Ag	N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes
AR041481A1 (es)	2002-10-07	2005-05-18	Hoffmann La Roche	Derivados de acido arilpropionico-oxazol y su uso como agonistas de ppar
MXPA05005445A (es)	2002-11-25	2005-08-26	Hoffmann La Roche	Derivados de indolilo.
US7192970B2 (en)	2002-11-26	2007-03-20	Chipscreen Biosciences, Ltd.	Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity
US7268157B2 (en)	2002-11-26	2007-09-11	Shenzhen Chipscreen Biosciences, Ltd.	Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity
RU2342362C2 (ru) *	2002-11-26	2008-12-27	Шэньчжэнь Чипскрин Байосайенсиз Лтд.	Замещенные производные арилалкановой кислоты как пан агонисты рапп с высокой антигипергликемической и антигиперлипидемической активностью
AU2004251829B2 (en)	2003-06-20	2009-12-17	F. Hoffmann-La Roche Ag	Hexahydropyridoisoqinolines as DPP-IV inhibitors
HRP20110018T1 (hr)	2003-06-20	2011-02-28	F. Hoffmann - La Roche Ag	Derivati pirido(2,1-a)-izokinolina kao inhibitori dpp-iv
US7825278B2 (en)	2004-05-06	2010-11-02	The Regents Of The University Of California	Substituted enaminones, their derivatives and uses thereof
CN100436430C (zh) *	2004-05-24	2008-11-26	北京摩力克科技有限公司	作为hPPARα和hPPARγ激动剂的烷酰基取代的酪氨酸衍生物
CN100344618C (zh) *	2004-05-24	2007-10-24	北京摩力克科技有限公司	作为hPPARα和hPPARγ激动剂的N－芳丙烯酰基取代的酪氨酸衍生物
CN100467456C (zh)	2004-05-24	2009-03-11	北京摩力克科技有限公司	作为hPPARα和/或hPPARγ激活剂的α-哌嗪取代的苯丙酸衍生物
CN1896069B (zh) *	2005-07-15	2011-10-05	中国科学院上海药物研究所	一类取代噻唑-4酮化合物、制备方法和用途
CN101007790B (zh) *	2006-01-27	2011-03-30	北京摩力克科技有限公司	草氨酸衍生物、其制备方法和医药用途
JP4999923B2 (ja) *	2006-06-13	2012-08-15	中国科学院上海薬物研究所	複素環非ヌクレオシド系化合物、抗ウィルス医薬組成物、及びウィルス性疾病治療薬物
GB0719180D0 (en) *	2007-10-02	2007-11-14	Cambrex Karlskoga Ab	New process
EP2135865A1 (de)	2008-06-17	2009-12-23	Bayer CropScience AG	Substituierte 1-(Diazinyl) pyrazol-4-yl-essigsäuren, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren
EP2194052A1 (de)	2008-12-06	2010-06-09	Bayer CropScience AG	Substituierte 1-(Thiazolyl)- und 1-(Isothiazolyl)pyrazol-4-yl-essigsäuren, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren
WO2011073098A1 (de)	2009-12-15	2011-06-23	Bayer Cropscience Ag	1-(heteroaryl)-pyrazol-4-yl-essigsäuren, verfahren zu deren herstellung und deren verwendung als herbizide und pflanzenwachstumsregulatoren
US20120094959A1 (en)	2010-10-19	2012-04-19	Bonnie Blazer-Yost	Treatment of cystic diseases
CN116367861A (zh) *	2020-09-14	2023-06-30	上海弼领生物技术有限公司	PPARα（过氧化物酶体增殖物激活受体α）配体在制备药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5089514A (en)	1990-06-14	1992-02-18	Pfizer Inc.	3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
US6062509A (en)	1994-12-23	2000-05-16	Hexcel Corporation	Retrofit centerline luggage bin assemblies compatible with existing aircraft bin supports
JPH08325263A (ja) *	1995-05-31	1996-12-10	Sumitomo Metal Ind Ltd	新規２−アミノ−３−フェニルプロピオン酸誘導体
GB9604242D0 (en)	1996-02-28	1996-05-01	Glaxo Wellcome Inc	Chemical compounds
EE03765B1 (et) *	1996-08-19	2002-06-17	Japan Tobacco Inc.	Propioonhappe derivaadid ja nende kasutamine

1998
- 1998-08-07 GB GBGB9817118.4A patent/GB9817118D0/en not_active Ceased
1999
- 1999-08-04 AR ARP990103874A patent/AR020001A1/es not_active Application Discontinuation
- 1999-08-04 CO CO99049333A patent/CO5070570A1/es unknown
- 1999-08-05 MA MA25716A patent/MA26668A1/fr unknown
- 1999-08-05 CZ CZ2001490A patent/CZ2001490A3/cs unknown
- 1999-08-05 IL IL14124899A patent/IL141248A0/xx unknown
- 1999-08-05 CN CN99811640A patent/CN1321152A/zh active Pending
- 1999-08-05 PE PE1999000790A patent/PE20000947A1/es not_active Application Discontinuation
- 1999-08-05 CA CA002339773A patent/CA2339773A1/en not_active Abandoned
- 1999-08-05 WO PCT/EP1999/005666 patent/WO2000008002A1/en not_active Ceased
- 1999-08-05 ES ES99944335T patent/ES2220110T3/es not_active Expired - Lifetime
- 1999-08-05 SK SK196-2001A patent/SK1962001A3/sk unknown
- 1999-08-05 KR KR1020017001617A patent/KR20010085340A/ko not_active Withdrawn
- 1999-08-05 PL PL99345882A patent/PL345882A1/xx not_active Application Discontinuation
- 1999-08-05 US US09/762,445 patent/US6498174B1/en not_active Expired - Fee Related
- 1999-08-05 AU AU57310/99A patent/AU5731099A/en not_active Abandoned
- 1999-08-05 EP EP99944335A patent/EP1102757B1/en not_active Expired - Lifetime
- 1999-08-05 BR BR9912866-7A patent/BR9912866A/pt not_active Application Discontinuation
- 1999-08-05 HU HU0103469A patent/HUP0103469A3/hu unknown
- 1999-08-05 ID IDW20010541A patent/ID29543A/id unknown
- 1999-08-05 JP JP2000563635A patent/JP2002522426A/ja active Pending
- 1999-08-05 AT AT99944335T patent/ATE264313T1/de not_active IP Right Cessation
- 1999-08-05 DE DE69916457T patent/DE69916457T2/de not_active Expired - Lifetime
- 1999-08-05 AP APAP/P/2001/002066A patent/AP2001002066A0/en unknown
- 1999-08-05 EE EEP200100074A patent/EE200100074A/xx unknown
- 1999-08-05 TR TR2001/00372T patent/TR200100372T2/xx unknown
- 1999-08-05 EA EA200100105A patent/EA200100105A1/ru unknown
- 1999-08-05 HR HR20010095A patent/HRP20010095A2/hr not_active Application Discontinuation
2001
- 2001-02-05 IS IS5840A patent/IS5840A/is unknown
- 2001-02-05 ZA ZA200100983A patent/ZA200100983B/en unknown
- 2001-02-06 NO NO20010628A patent/NO20010628L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1102757B1 (en)	2004-04-14
BR9912866A (pt)	2001-10-30
HRP20010095A2 (en)	2002-02-28
IL141248A0 (en)	2002-03-10
AR020001A1 (es)	2002-03-27
SK1962001A3 (en)	2001-11-06
CZ2001490A3 (cs)	2001-08-15
WO2000008002A1 (en)	2000-02-17
ES2220110T3 (es)	2004-12-01
AP2001002066A0 (en)	2001-03-31
ATE264313T1 (de)	2004-04-15
US6498174B1 (en)	2002-12-24
HUP0103469A3 (en)	2002-08-28
EA200100105A1 (ru)	2001-08-27
NO20010628L (no)	2001-04-06
CN1321152A (zh)	2001-11-07
ZA200100983B (en)	2002-03-05
AU5731099A (en)	2000-02-28
MA26668A1 (fr)	2004-12-20
CA2339773A1 (en)	2000-02-17
TR200100372T2 (tr)	2001-09-21
EE200100074A (et)	2002-06-17
NO20010628D0 (no)	2001-02-06
HUP0103469A2 (hu)	2002-01-28
KR20010085340A (ko)	2001-09-07
PL345882A1 (en)	2002-01-14
CO5070570A1 (es)	2001-08-28
ID29543A (id)	2001-09-06
DE69916457D1 (de)	2004-05-19
JP2002522426A (ja)	2002-07-23
GB9817118D0 (en)	1998-10-07
DE69916457T2 (de)	2005-04-14
EP1102757A1 (en)	2001-05-30
PE20000947A1 (es)	2000-09-22

Publication	Publication Date	Title
IS5840A (is)	2001-02-05	Setnar oxazól og þíazól afleiður sem hPPAR gamma og hPPAR alfa hvatar
DK1244642T3 (da)	2004-08-16	Substituerede oxazol- og thiazolderivater som HPPAR-alfa-aktivatorer
IL147939A0 (en)	2002-08-14	Oxazole and thiazole derivatives and pharmaceutical compositions containing the same
DK1206472T3 (da)	2004-01-12	Oxazol- og thiazolderivater som neutrophinproduktions/sekretionsfremmende middel
NO20006163L (no)	2001-02-02	Lastearrangement
DK1231918T3 (da)	2005-08-01	Hidtil ukendt præparat baseret på en thiazolidindion og metformin og anvendelse deraf
IL146634A0 (en)	2002-07-25	Thiazole and oxazole derivatives and their pharmaceutical use
NO20004156L (no)	2001-02-21	MTO-reaktor med hurtig-fluidiserende bed
NO20014419L (no)	2001-12-03	Setteverktöysammenstilling for oppblåsbare pakninger
DK0928790T3 (da)	2003-06-30	Thiazolderivater
DE3770515D1 (de)	1991-07-11	Amino-thiazol- und -oxazolderivate.
ID29886A (id)	2001-10-18	Pengepakan benda-benda fleksibel
PT102054A (pt)	1998-04-30	Composicao para o tratamento de sementes de arroz
NO20035209D0 (no)	2003-11-24	Oksazol/Tiazol-derivataktivatorer av HPPAR-alfa reseptoren
FI991616L (fi)	1999-07-16	Pramipeksolin käyttö levottomien jalkojen oireyhtymän hoidossa
PL341340A1 (en)	2001-04-09	Fungicidal mixtures on the basis of amidic compounds and derivatives of morpholine or piperidine
ATE266012T1 (de)	2004-05-15	Thiazole derivate
DE69805392D1 (de)	2002-06-20	Thiazol-Derivate
HK1035191A (en)	2001-11-16	Substituted oxazole and thiazole derivatives as hppar gamma and hppar alpha activators
NO20035652L (no)	2004-02-25	Tiaziner og tiazoler som materialbeskyttelsesmidler
SI1244642T1 (en)	2004-12-31	Substituted oxazoles and thiazoles derivatives as hppar alpha activators
PT999910E (pt)	2003-09-30	Maquina-ferramenta e funcionamento de uma maquina-ferramenta no fabrico de cambotas